Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 38

References for PMC Articles for PubMed (Select 23034333)

1.

FoxM1 promotes β-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis.

Zhang N, Wei P, Gong A, Chiu WT, Lee HT, Colman H, Huang H, Xue J, Liu M, Wang Y, Sawaya R, Xie K, Yung WK, Medema RH, He X, Huang S.

Cancer Cell. 2011 Oct 18;20(4):427-42. doi: 10.1016/j.ccr.2011.08.016.

2.

Human glioma growth is controlled by microRNA-10b.

Gabriely G, Yi M, Narayan RS, Niers JM, Wurdinger T, Imitola J, Ligon KL, Kesari S, Esau C, Stephens RM, Tannous BA, Krichevsky AM.

Cancer Res. 2011 May 15;71(10):3563-72. doi: 10.1158/0008-5472.CAN-10-3568. Epub 2011 Apr 6.

3.

MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10.

Sun L, Yan W, Wang Y, Sun G, Luo H, Zhang J, Wang X, You Y, Yang Z, Liu N.

Brain Res. 2011 May 10;1389:9-18. doi: 10.1016/j.brainres.2011.03.013. Epub 2011 Mar 16.

PMID:
21419107
4.

Cancer stem-like cells of glioblastoma characteristically express MMP-13 and display highly invasive activity.

Inoue A, Takahashi H, Harada H, Kohno S, Ohue S, Kobayashi K, Yano H, Tanaka J, Ohnishi T.

Int J Oncol. 2010 Nov;37(5):1121-31.

PMID:
20878060
5.

The proneural molecular signature is enriched in oligodendrogliomas and predicts improved survival among diffuse gliomas.

Cooper LA, Gutman DA, Long Q, Johnson BA, Cholleti SR, Kurc T, Saltz JH, Brat DJ, Moreno CS.

PLoS One. 2010 Sep 3;5(9):e12548. doi: 10.1371/journal.pone.0012548.

6.

MicroRNA-10b regulates tumorigenesis in neurofibromatosis type 1.

Chai G, Liu N, Ma J, Li H, Oblinger JL, Prahalad AK, Gong M, Chang LS, Wallace M, Muir D, Guha A, Phipps RJ, Hock JM, Yu X.

Cancer Sci. 2010 Sep;101(9):1997-2004. doi: 10.1111/j.1349-7006.2010.01616.x.

PMID:
20550523
7.

RECK is up-regulated and involved in chondrocyte cloning in human osteoarthritic cartilage.

Kimura T, Okada A, Yatabe T, Okubo M, Toyama Y, Noda M, Okada Y.

Am J Pathol. 2010 Jun;176(6):2858-67. doi: 10.2353/ajpath.2010.091003. Epub 2010 Apr 15.

8.

Loss of the tumor suppressor CYLD enhances Wnt/beta-catenin signaling through K63-linked ubiquitination of Dvl.

Tauriello DV, Haegebarth A, Kuper I, Edelmann MJ, Henraat M, Canninga-van Dijk MR, Kessler BM, Clevers H, Maurice MM.

Mol Cell. 2010 Mar 12;37(5):607-19. doi: 10.1016/j.molcel.2010.01.035.

9.

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.

Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, Alexe G, Lawrence M, O'Kelly M, Tamayo P, Weir BA, Gabriel S, Winckler W, Gupta S, Jakkula L, Feiler HS, Hodgson JG, James CD, Sarkaria JN, Brennan C, Kahn A, Spellman PT, Wilson RK, Speed TP, Gray JW, Meyerson M, Getz G, Perou CM, Hayes DN; Cancer Genome Atlas Research Network.

Cancer Cell. 2010 Jan 19;17(1):98-110. doi: 10.1016/j.ccr.2009.12.020.

10.

The transcriptional network for mesenchymal transformation of brain tumours.

Carro MS, Lim WK, Alvarez MJ, Bollo RJ, Zhao X, Snyder EY, Sulman EP, Anne SL, Doetsch F, Colman H, Lasorella A, Aldape K, Califano A, Iavarone A.

Nature. 2010 Jan 21;463(7279):318-25. doi: 10.1038/nature08712. Epub 2009 Dec 23.

11.

Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations.

Brennan C, Momota H, Hambardzumyan D, Ozawa T, Tandon A, Pedraza A, Holland E.

PLoS One. 2009 Nov 13;4(11):e7752. doi: 10.1371/journal.pone.0007752.

12.

Tumor suppressor U19/EAF2 regulates thrombospondin-1 expression via p53.

Su F, Pascal LE, Xiao W, Wang Z.

Oncogene. 2010 Jan 21;29(3):421-31. doi: 10.1038/onc.2009.326. Epub 2009 Oct 12.

13.

Hedgehog activation is required upstream of Wnt signalling to control neural progenitor proliferation.

Alvarez-Medina R, Le Dreau G, Ros M, Martí E.

Development. 2009 Oct;136(19):3301-9. doi: 10.1242/dev.041772.

14.

PAX6 suppression of glioma angiogenesis and the expression of vascular endothelial growth factor A.

Zhou YH, Hu Y, Mayes D, Siegel E, Kim JG, Mathews MS, Hsu N, Eskander D, Yu O, Tromberg BJ, Linskey ME.

J Neurooncol. 2010 Jan;96(2):191-200. doi: 10.1007/s11060-009-9963-8. Epub 2009 Jul 19.

16.

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.

Huang da W, Sherman BT, Lempicki RA.

Nat Protoc. 2009;4(1):44-57. doi: 10.1038/nprot.2008.211.

17.

A highly invasive human glioblastoma pre-clinical model for testing therapeutics.

Xie Q, Thompson R, Hardy K, DeCamp L, Berghuis B, Sigler R, Knudsen B, Cottingham S, Zhao P, Dykema K, Cao B, Resau J, Hay R, Vande Woude GF.

J Transl Med. 2008 Dec 3;6:77. doi: 10.1186/1479-5876-6-77.

18.

The angiopoietin 1/angiopoietin 2 balance as a prognostic marker in primary glioblastoma multiforme.

Sie M, Wagemakers M, Molema G, Mooij JJ, de Bont ES, den Dunnen WF.

J Neurosurg. 2009 Jan;110(1):147-55. doi: 10.3171/2008.6.17612.

PMID:
18991494
19.

FoxM1B transcriptionally regulates vascular endothelial growth factor expression and promotes the angiogenesis and growth of glioma cells.

Zhang Y, Zhang N, Dai B, Liu M, Sawaya R, Xie K, Huang S.

Cancer Res. 2008 Nov 1;68(21):8733-42. doi: 10.1158/0008-5472.CAN-08-1968.

20.

Comprehensive genomic characterization defines human glioblastoma genes and core pathways.

Cancer Genome Atlas Research Network.

Nature. 2008 Oct 23;455(7216):1061-8. doi: 10.1038/nature07385. Epub 2008 Sep 4. Erratum in: Nature. 2013 Feb 28;494(7438):506.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk